5% Dimethyl sulfoxide (DMSO) and pentastarch improves cryopreservation of cord blood cells over 10% DMSO

Transfusion

Volumn 50, Issue 10, 2010, Pages 2158-2166

  Hayakawa, Jun ^a,b,c,d   Joyal, Elizabeth G ^a,b,c,d   Gildner, Jean F ^a,b,c,d   Washington, Kareem N ^a,b,c,d   Phang, Oswald A ^a,b,c,d   Uchida, Naoya ^a,b,c,d   Hsieh, Matthew M ^a,b,c,d   Tisdale, John F ^a,b,c,d  

^a Molecular and Clinical Hematology Branch (MCHB)   (United States)

^b National Institutes of Diabetes and Digestive and Kidney Disorders (NIDDK)   (United States)

^c NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIMETHYL SULFOXIDE; HETASTARCH;

ANIMAL EXPERIMENT; ARTICLE; CD3+ T LYMPHOCYTE; CD34 SELECTION; CELL VIABILITY; COLONY FORMING UNIT; COMPARATIVE STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; CRYOPRESERVATION; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; UMBILICAL CORD BLOOD;

ANIMALS; ANTIGENS, CD34; BLOOD PRESERVATION; CELL SURVIVAL; CRYOPRESERVATION; CRYOPROTECTIVE AGENTS; DIMETHYL SULFOXIDE; FETAL BLOOD; HETASTARCH; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MICE; MICE, INBRED NOD; MICE, SCID;

EID: 78649477222     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2010.02684.x     Document Type: Article

References (50)

1. Wagner JE, Rosenthal J, Sweetman R, Shu XO, Davies SM, Ramsay NK, McGlave PB, Sender L, Cairo MS. Successful transplantation of HLA-matched and HLA-mismatched umbilical cord blood from unrelated donors: analysis of engraftment and acute graft-versus-host disease. Blood 1996;88:795-802.
2. Gluckman E, Rocha V, Boyer-Chammard A, Locatelli F, Arcese W, Pasquini R, Ortega J, Souillet G, Ferreira E, Laporte JP, Fernandez M, Chastang C. Outcome of cordblood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation Group. N Engl J Med 1997;337: 373-81.
3. Laughlin MJ, Barker J, Bambach B, Koc ON, Rizzieri DA, Wagner JE, Gerson SL, Lazarus HM, Cairo M, Stevens CE, Rubinstein P, Kurtzberg J. Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. N Engl J Med 2001;344:1815-22.
4. Rubinstein P, Carrier C, Scaradavou A, Kurtzberg J, Adamson J, Migliaccio AR, Berkowitz RL, Cabbad M, Dobrila NL, Taylor PE, Rosenfield RE, Stevens CE. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med 1998;339:1565-77.
5. Barker JN, Weisdorf DJ, Wagner JE. Creation of a double chimera after the transplantation of umbilical-cord blood from two partially matched unrelated donors. N Engl J Med 2001;344:1870-1.
6. Barker JN, Weisdorf DJ, DeFor TE, Blazar BR, McGlave PB, Miller JS, Verfaillie CM, Wagner JE. Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy. Blood 2005;105:1343-7.
7. Lewis JP, Passovoy M, Conti SA, McFate PA, Trobaugh FE Jr. The effect of cooling regimens on the transplantation potential of marrow. Transfusion 1967;7:17-32.
8. Ketheesan N, Whiteman C, Malczewski AB, Hirst RG, La Brooy JT. Effect of cryopreservation on the immunogenicity of umbilical cord blood cells. Transfus Apher Sci 2004; 30:47-54.
9. Aird W, Labopin M, Gorin NC, Antin JH. Long-term cryopreservation of human stem cells. Bone Marrow Transplant 1992;9:487-90.
10. Silberstein LE, Jefferies LC. Placental-blood banking-a new frontier in transfusion medicine. N Engl J Med 1996; 335:199-201.
11. Yang H, Zhao H, Acker JP, Liu JZ, Akabutu J, McGann LE. Effect of dimethyl sulfoxide on post-thaw viability assessment of CD45+ and CD34+ cells of umbilical cord blood and mobilized peripheral blood. Cryobiology 2005;51:165-75.
12. Mericka P, Schustr P, Vins M, Dudek A, Vávra L, Cervinka M, Rondiak J. Containers for freezing and storage of bone marrow stem cells. Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove 1991;34:367-87.
13. Campos L, Roubi N, Guyotat D. Definition of optimal conditions for collection and cryopreservation of umbilical cord hematopoietic cells. Cryobiology 1995;32:511-5.
14. Nicol A, Nieda M, Donaldson C, Denning-Kendall P, Bradley B, Hows J. Analysis of cord blood CD34+ cells purified after cryopreservation. Exp Hematol 1995;23:1589-94.
15. Donaldson C, Armitage WJ, Denning-Kendall PA, Nicol AJ, Bradley BA, Hows JM. Optimal cryopreservation of human umbilical cord blood. Bone Marrow Transplant 1996;18: 725-31.
16. Shlebak AA, Marley SB, Roberts IA, Davidson RJ, Goldman JM, Gordon MY. Optimal timing for processing and cryopreservation of umbilical cord haematopoietic stem cells for clinical transplantation. Bone marrow Transplant 1999; 23:131-6.
17. Broxmeyer HE, Srour EF, Hangoc G, Cooper S, Anderson SA, Bodine DM. High-efficiency recovery of functional hematopoietic progenitor and stem cells from human cord blood cryopreserved for 15 years. Proc Natl Acad Sci U S A 2003;100:645-50.
18. Zambelli A, Poggi G, Da Prada G, Pedrazzoli P, Cuomo A, Miotti D, Perotti C, Preti P, Robustelli della Cuna G. Clinical toxicity of cryopreserved circulating progenitor cells infusion. Anticancer Res 1998;18:4705-8.
19. Davis JM, Rowley SD, Braine HG, Piantadosi S, Santos GW. Clinical toxicity of cryopreserved bone marrow graft infusion. Blood 1990;75:781-6.
20. Benekli M, Anderson B, Wentling D, Bernstein S, Czuczman M, McCarthy P. Severe respiratory depression after dimethylsulphoxide-containing autologous stem cell infusion in a patient with AL amyloidosis. Bone Marrow Transplant 2000;25:1299-301.
21. Miniero R, Vai S, Giacchino M, Giubellino C, Madon E. Severe respiratory depression after autologous bone marrow infusion. Haematologica 1992;77:98-9.
22. Hequet O, Dumontet C, El Jaafari-Corbin A, Salles G, Espinouse D, Arnaud P, Thieblemont C, Bouafia F, Coiffier B. Epileptic seizures after autologous peripheral blood progenitor infusion in a patient treated with high-dose chemotherapy for myeloma. Bone Marrow Transplant 2002;29: 544.
23. Higman MA, Port JD, Beauchamp NJ Jr, Chen AR. Reversible leukoencephalopathy associated with re-infusion of DMSO preserved stem cells. Bone Marrow Transplant 2000; 26:797-800.
24. Burger J, Gilmore MJ, Jackson B, Prentice HG. Acute haemoglobinaemia associated with the reinfusion of bone marrow buffy coat for autologous bone marrow transplantation. Bone Marrow Transplant 1991;7:322-4.
25. Halle P, Tournilhac O, Knopinska-Posluszny W, Kanold J, Gembara P, Boiret N, Rapatel C, Berger M, Travade P, Angielski S, Bonhomme J, Deméocq F. Uncontrolled-rate freezing and storage at -80 degrees C, with only 3.5- percent DMSO in cryoprotective solution for 109 autologous peripheral blood progenitor cell transplantations. Transfusion 2001;41:667-73.
26. Katayama Y, Yano T, Bessho A, Deguchi S, Sunami K, Mahmut N, Shinagawa K, Omoto E, Makino S, Miyamoto T, Mizuno S, Fukuda T, Eto T, Fujisaki T, Ohno Y, Inaba S, Niho Y, Harada M. The effects of a simplified method for cryopreservation and thawing procedures on peripheral blood stem cells. Bone Marrow Transplant 1997;19:283-7.
27. Rowley SD, Feng Z, Chen L, Holmberg L, Heimfeld S, MacLeod B, Bensinger WI. A randomized phase III clinical trial of autologous blood stem cell transplantation comparing cryopreservation using dimethylsulfoxide vs dimethylsulfoxide with hydroxyethylstarch. Bone Marrow Transplantat 2003;31:1043-51.
28. Brunkhorst FM, Engel C, Bloos F, Meier-Hellmann A, Ragaller M, Weiler N, Moerer O, Gruendling M, Oppert M, Grond S, Olthoff D, Jaschinski U, John S, Rossaint R, Welte T, Schaefer M, Kern P, Kuhnt E, Kiehntopf M, Hartog C, Natanson C, Loeffler M, Reinhart K; German Competence Network Sepsis (SepNet). Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 2008;358:125-39.
29. Ganzevoort W, Rep A, Bonsel GJ, Fetter W.P., van Sonderen L, De Vries JI, Wolf H; PETRA Investigators. A randomised controlled trial comparing two temporising management strategies, one with and one without plasma volume expansion, for severe and early onset pre-eclampsia. BJOG 2005;112:1358-68.
30. Riley ET, Cohen SE, Rubenstein AJ, Flanagan B. Prevention of hypotension after spinal anesthesia for cesarean section: six percent hetastarch versus lactated Ringer's solution. Anesth Analg 1995;81:838-42.
31. French GW, White JB, Howell SJ, Popat M. Comparison of pentastarch and Hartmann's solution for volume preloading in spinal anaesthesia for elective caesarean section. Br J Anaesth 1999;83:475-7.
32. Yang H, Acker JP, Abley D, McGann LE, Akabutu J. Highefficiency volume reduction of cord blood using pentastarch. Bone Marrow Transplant 2001;27:457-61.
33. Solves P, Mirabet V, Planelles D, Blasco I, Perales A, Carbonell-Uberos F, Soler MA, Roig R. Red blood cell depletion with a semiautomated system or hydroxyethyl starch sedimentation for routine cord blood banking: a comparative study. Transfusion 2005;45:867-73.
34. Strauss RG, Pennell BJ, Stump DC. A randomized, blinded trial comparing the hemostatic effects of pentastarch versus hetastarch. Transfusion 2002;42:27-36.
35. Areman EM, Deeg HJ, Sacher RA. Bone marrow and stem cell processing: a manual of current techniques. Philadelphia (PA): FA Davis Co; 1992.
36. Berz D, McCormack EM, Winer ES, Colvin GA, Quesenberry PJ. Cryopreservation of hematopoietic stem cells. Am J Hematol 2007;82:463-72.
37. Lecoeur H, Ledru E, Prevost MC, Gougeon ML. Strategies for phenotyping apoptotic peripheral human lymphocytes comparing ISNT, annexin-V and 7-AAD cytofluorometric staining methods. J Immunol Methods 1997;209:111-23.
38. Ishikawa F, Yasukawa M, Lyons B, Yoshida S, Miyamoto T, Yoshimoto G, Watanabe T, Akashi K, Shultz LD, Harada M. Development of functional human blood and immune systems in NOD/SCID/IL2 receptor {gamma} chain(null) mice. Blood 2005;106:1565-73.
39. Shultz LD, Lyons BL, Burzenski LM, Gott B, Chen X, Chaleff S, Kotb M, Gillies SD, King M, Mangada J, Greiner DL, Handgretinger R. Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2R gamma null mice engrafted with mobilized human hemopoietic stem cells. J Immunol 2005;174:6477-89.
40. Hayakawa J, Hsieh MM, Uchida N, Phang O, Tisdale JF. Busulfan produces efficient human cell engraftment in NOD/LtSz-Scid IL2Rgamma(null) mice. Stem Cells 2009; 27:175-82.
41. Hayakawa J, Migita M, Ueda T, Shimada T, Fukunaga Y. Generation of a chimeric mouse reconstituted with green fluorescent protein-positive bone marrow cells: a useful model for studying the behavior of bone marrow cells in regeneration in vivo. Int J Hematol 2003;77:456-62.
42. Abrahamsen JF, Rusten L, Bakken AM, Bruserud O. Better preservation of early hematopoietic progenitor cells when human peripheral blood progenitor cells are cryopreserved with 5 percent dimethylsulfoxide instead of 10 percent dimethylsulfoxide. Transfusion 2004;44:785-9.
43. Kang EM, Areman EM, David-Ocampo V, Fitzhugh C, Link ME, Read EJ, Leitman SF, Rodgers GP, Tisdale JF. Mobilization, collection, and processing of peripheral blood stem cells in individuals with sickle cell trait. Blood 2002;99: 850-5.
44. Liseth K, Abrahamsen JF, Bjorsvik S, Grottebo K, Bruserud O. The viability of cryopreserved PBPC depends on the DMSO concentration and the concentration of nucleated cells in the graft. Cytotherapy 2005;7:328-33.
45. Sasnoor LM, Kale VP, Limaye LS. Supplementation of conventional freezing medium with a combination of catalase and trehalose results in better protection of surface molecules and functionality of hematopoietic cells. J Hematother Stem Cell Res 2003;12:553-64.
46. Solves P, Mirabet V, Planelles D, Carbonell-Uberos F, Roig R. Influence of volume reduction and cryopreservation methodologies on quality of thawed umbilical cord blood units for transplantation. Cryobiology 2008;56:152-8.
47. Stylianou J, Vowels M, Hadfield K. Novel cryoprotectant significantly improves the post-thaw recovery and quality of HSC from CB. Cytotherapy 2006;8:57-61.
48. Yasutake M, Zheng Y, Inoue-Nagamura T, Kagawa E, Tokushima Y, Terashima S, Takahashi TA. CIDrepopulating activity of human umbilical cord bloodderived hematopoietic stem and/or progenitor cells in a nonobese diabetic/Shi-SCID mice serial xenotransplantation model and immune cell activities in vitro: a comparative study of the filter method and the hydroxyethyl starch method. Transfusion 2005;45:1899-908.
49. Zhang XB, Li K, Yau KH, Tsang KS, Fok TF, Li CK, Lee SM, Yuen PM. Trehalose ameliorates the cryopreservation of cord blood in a preclinical system and increases the recovery of CFUs, long-term culture-initiating cells, and nonobese diabetic-SCID repopulating cells. Transfusion 2003; 43:265-72.
50. London MJ, Ho JS, Triedman JK, Verrier ED, Levin J, Merrick SH, Hanley FL, Browner WS, Mangano DT. A randomized clinical trial of 10% pentastarch (low molecular weight hydroxyethyl starch) versus 5% albumin for plasma volume expansion after cardiac operations. J Thorac Cardiovasc Surg 1989;97:785-97.